Kolexia
Roumier Christophe Pharmacien
Roumier Christophe
Pharmacien
Hôpital Albert Calmette
Lille, France
93 Activités
5 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Macroglobulinémie de Waldenström Maladie résiduelle Leucémie-lymphome lymphoblastique à précurseurs B et T Aberrations des chromosomes Lymphomes Tumeurs hématologiques

Collaborateurs

Voir plus
Preudhomme Claude
Preudhomme Claude
Hôpital Albert Calmette, Lille, France
Quesnel Bruno
Quesnel Bruno
Hôpital Huriez, Lille, France
Nibourel Olivier
Nibourel Olivier
Hôpital Albert Calmette, Lille, France
Renneville Aline
Renneville Aline
Gustave-Roussy, Villejuif, France

Industries

Voir plus
Celgene
2 collaboration(s)
Dernière en 2019
Janssen
1 collaboration(s)
Dernière en 2019
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Tetraspanin CD81 Supports Cancer Stem Cell Function and Represents a Therapeutic Vulnerability in Acute Myeloid Leukemia
65th ASH Annual Meeting Abstracts   02 novembre 2023
Outcomes for Children with High Risk Acute Myeloid Leukemia on the Myechild 01 International Phase III Clinical Trial
65th ASH Annual Meeting Abstracts   02 novembre 2023
Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): PRATICAL USE OF MONOCYTE SUBSET BY FLOW CYTOMETRY AND SEQUENCING IN DIAGNOSIS AND PROGNOSIS OF CLINICAL RELEVANT MONOCYTOSIS
The 17th International Congress on Myelodysplastic Syndromes   01 mai 2023
Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively.
HemaSphere   19 décembre 2022
Standard Risk-Assessment of AML Doesn't Predict the Outcome in Older AML Patients Undergoing Non-Intensive Chemotherapy
Annual Meeting Abstracts 2022   15 novembre 2022
AML MRD By Multiparameter Flow Cytometry Using Laip/Dfn and LSC: Methodological Aspects in a Multicentric Study of the French-Flow MRD AML ALFA Network
Annual Meeting Abstracts 2022   15 novembre 2022
Correlation of Clonal Hematopoiesis in Vexas Syndrome with Immunophenotype Alterations in CD34+ HSPCs (Hematopoietic Stem Progenitors Cells): Multiparametric Flow Cytometry Heterogeneity in CD34+CD38- Stem Cells Fraction and Upregulation of CD90 Thy-1 By Unsupervised Strategy Using PCA, Tsnee and Flowsom
Annual Meeting Abstracts 2022   15 novembre 2022
Modulation of monocytes inflammatory and hemostatic phenotype after transcatheter aortic valve replacement and consequences on post-procedural complications
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML.
Blood cancer journal   23 septembre 2022
Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia.
Journal for immunotherapy of cancer   12 juillet 2022